Roche Holding AG buy phonebroker
Start price
30.01.12
/
50%
€136.35
Target price
18.04.12
€160.00
Performance (%)
8.62%
End price
18.04.12
€142.47
Summary
This prediction ended on 18.04.12 with a price of €142.47. The BUY prediction by phonebroker finished with a performance of 8.62%. phonebroker has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Roche Holding AG | - | - | - | - |
iShares Core DAX® | 1.454% | 0.904% | 16.592% | 16.557% |
iShares Nasdaq 100 | -0.913% | 3.463% | 36.062% | 50.205% |
iShares Nikkei 225® | 2.355% | 3.830% | 14.881% | 10.110% |
iShares S&P 500 | 0.283% | 2.639% | 29.599% | 44.509% |
Comments by phonebroker for this prediction
In the thread Roche Holding AG diskutieren
US-Zulassung fuer Hautkrebsmittel
FDA hat Zulassung fuer Erivedge zu Hautkrebsbehandlung erteilt.
Euro am Sonntag stuft den Titel als verlaesslichen Dividendenzahler, mit Aussicht auf Kurssteigerung ein.
(Vom Mitglied beendet)